Galectin antagonist use in mild cases of SARS-CoV-2; pilot feasibility randomised, open label, controlled trial

Alben Sigamani, Samarth Shetty, Madhavi, Mathu Ruthra, Sudhishma, Anup Chugani, Hana Chen-Walden, ThomasKutty, David Platt
doi: https://doi.org/10.1101/2020.12.03.20238840

Data Availability

This is a pilot and feasibility trial. The data is available in a secure database and is locked within a REDCap electronic database.

Back to top
Posted December 09, 2020.
Download PDF
Data/Code
Email
Galectin antagonist use in mild cases of SARS-CoV-2; pilot feasibility randomised, open label, controlled trial
Alben Sigamani, Samarth Shetty, Madhavi, Mathu Ruthra, Sudhishma, Anup Chugani, Hana Chen-Walden, ThomasKutty, David Platt
medRxiv 2020.12.03.20238840; doi: https://doi.org/10.1101/2020.12.03.20238840
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area